Mode of action of three structurally different hypoglycemic agents: a comparative study

Area of Science:

• Pharmacology
• Natural Products Chemistry
• Endocrinology

Background:

• Diabetes mellitus is a metabolic disorder characterized by hyperglycemia.
• Exploring novel hypoglycemic agents from natural sources and synthetic compounds is crucial for diabetes management.
• Understanding the dose-response, safety, and efficacy of antidiabetic agents is essential.

Purpose of the Study:

• To investigate the dose-dependent hypoglycemic mechanisms, safety margins, and ED50 of tolbutamide (TB), centpiperalone (CP), and a Swertia chirayita fraction (SWI).
• To compare the efficacy of these agents in normal and streptozotocin (STZ)-induced diabetic rat models.

Main Methods:

• Oral administration of TB, CP, and SWI to normal and STZ-induced diabetic rats.
• Determination of blood glucose-lowering effects and ED50.
• Assay of plasma Immuno Reactive Insulin (IRI) levels using RIA.
• Histochemical staining to assess islet beta cell degranulation.

Main Results:

• Centpiperalone (CP) showed the highest blood sugar reduction (69%), IRI increase (124%), and beta cell degranulation (75%) in normal rats.
• CP was the only effective agent in severely diabetic rats (P < 0.01).
• Tolbutamide (TB) was more effective than CP and SWI in mild diabetic rats, while SWI showed better blood sugar lowering than TB despite being impure.

Conclusions:

• Centpiperalone (CP) exhibits superior hypoglycemic efficacy compared to tolbutamide (TB) and swerchirin (SWI).
• CP's effectiveness in severely diabetic models highlights its potential as an antidiabetic agent.
• The natural product SWI shows promising blood sugar-lowering activity, warranting further investigation.